Zusammenfassung
Die Ähnlichkeit der Klinik zwischen Morbus Johne, einer granulomatösen Enteritis bei Wiederkäuern, verursacht durch Mycobacterium paratuberculosis, abdomineller Tuberkulose und Morbus Crohn zum einen und Hinweise auf eine erhöhte Durchseuchung der Crohn-Patienten mit Mycobacterium paratuberculosis hat eine tuberkulöse Ätiologie der chronisch-entzündlichen Darmerkrankungen seit Anfang des letzten Jahrhunderts in der Diskussion gehalten. In diesem Artikel sollen wesentliche Argumente pro und contra zusammengefasst werden.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Burnham WR, Lennard-Jones JE, Stanford JL, Bird RG (1978) Mycobacteria as a possible cause of inflammatory bowel disease. Lancet 2: 693–696
Chiodini RJ, Van Kruiningen HJ, Thayer WR, Coutu JA (1986) Spheroplastic phase of mycobacteria isolated from patients with Crohn’s disease. J Clin Microbiol 24: 357–363
Chiodini RJ, Van Kruiningen HJ, Thayer WR, Merkal RS, Coutu JA (1984) Possible role of mycobacteria in inflammatory bowel disease. I. An unclassified Mycobacterium species isolated from patients with Crohn’s disease. Dig Dis Sci 29: 1073–1079
Collins MT, Lisby G, Moser C et al. (2000) Results of multiple diagnostic tests for Mycobacterium avium subsp. paratuberculosis in patients with inflammatory bowel disease and in controls. J Clin Microbiol 8: 4373–4381
Farthing MJG, Butcher PD (1988) Mycobacterium tuberculosis and paratuberculosis. In: Farthing MJG, Keusch GT (eds) Enteric infections. Raven Press, New York, pp 351–364
Fidler HM, Thurrell W, Johnson NM, Rook GA, McFadden JJ (1994) Specific detection of Mycobacterium paratuberculosis DNA associated with granulomatous tissue in Crohn’s disease. Gut 35: 506–510
Frank TS, Cook SM (1996) Analysis of paraffin sections of Crohn’s disease for Mycobacterium paratuberculosis using polymerase chain reaction. Mod Pathol 9: 32–35
Goodgame RW, Kimball K, Akram S, Graham DY, Ou CN (1999) Randomized controlled trial of clarithromycin and ethambutol in the treatment of Crohn’s disease. Gastroenterology 116 (4): A725
Graham DY, Al-Assi MT, Robinson M (1995) Prolonged remission in Crohn’s disease following therapy for Mycobacterium paratuberculosis infection. Gastroenterology 108 (4): A826
Graham DY, Markesich DC, Yoshimura HH (1987) Mycobacteria and inflammatory bowel disease. Results of culture. Gastroenterology 92: 436–442
Hampson SJ, Parker MC, Saverymuttu SH, Joseph AE, McFadden JJ, Hermon-Taylor J (1989) Quadruple antimycobacterial chemotherapy in Crohn’s disease: results at 9 months of a pilot study in 20 patients. Aliment Pharmacol Ther 3: 343–352
Kanazawa K, Haga Y, Funakoshi O, Nakajima H, Munakata A, Yoshida Y (1999) Absence of Mycobacterium paratuberculosis DNA in intestinal tissues from Crohn’s disease by nested polymerase chain reaction. J Gastroenterol 34: 200–206
Kreuzpaintner G, Das PK, Stronkhorst A, Slow AW, Strohmeyer G (1995) Effect of intestinal resection on serum antibodies to the mycobacterial 45/48 kilodalton doublet antigen in Crohn’s disease. Gut 37: 361–366
McFadden JJ, Houdayer C (1988) No evidence for antibodies to mycobacterial A60 antigen in Crohn’s disease sera by enzyme-linked immunoabsorbent assay ( ELISA ). J Med Microbiol 25: 295–298
Moss MT, Sanderson JD, Tizard ML, Hermon-Taylor J, el Zaatari FA, Markesich DC, Graham DY (1992) Polymerase chain reaction detection of Mycobacterium paratuberculosis and Mycobacterium avium subsp silvaticum in long term cultures from Crohn’s disease and control tissues. Gut 33: 1209–1213
Rowbotham DS, Mapstone NP, Trejdosiewicz LK, Howdle PD, Quirke P (1995) Mycobacterium paratuberculosis DNA not detected in Crohn’s disease tissue by fluorescent polymerase chain reaction. Gut 37: 660–667
Sanderson JD, Moss MT, Tizard ML, Hermon-Taylor J (1992) Mycobacterium paratuberculosis DNA in Crohn’s disease tissue. Gut 33: 890–896
Schultz MG, Rieder HL, Hersh T, Riepe S (1987) Remission of Crohn’s disease with antimycobacterial chemotherapy. Lancet 2: 1391–1392
Shaffer JL, Hughes S, Linaker BD, Baker RD, Turnberg LA (1984) Controlled trial of rifampicin and ethambutol in Crohn’s disease. Gut 25: 203–205
Stainsby KJ, Lowes JR, Allan RN, Ibbotson JP (1993) Antibodies to Mycobacterium paratuberculosis and nine species of environmental mycobacteria in Crohn’s disease and control subjects. Gut 34: 371–374
Suenaga K, Yokoyama Y, Okazaki K, Yamamoto Y (1995) Mycobacteria in the intestine of Japanese patients with inflammatory bowel disease. Am J Gastroenterol 90: 76–80
Thayer WR, Jr., Coutu JA, Chiodini RJ, Van Kruiningen HJ, Merkal RS (1984) Possible role of mycobacteria in inflammatory bowel disease. II. Mycobacterial antibodies in Crohn’s disease. Dig Dis Sci 29: 1080–1085
Van Kruiningen HJ (1999) Lack of support for a common etiology in Johne’s disease of animals and Crohn’s disease in humans. Inflamm Bowel Dis 5: 183–191
Walmsley RS, Ibbotson JP, Chahal H, Allan RN (1996) Antibodies against Mycobacterium paratuberculosis in Crohn’s disease. Q J Med 89: 217–221
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Rath, H.C. (2001). Tuberkulose, atypische Mykobakterien. In: Stein, J., Dignass, A. (eds) Chronisch entzündliche Darmerkrankungen. Gastroenterologie Update, vol 2001. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59505-9_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-59505-9_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-42509-0
Online ISBN: 978-3-642-59505-9
eBook Packages: Springer Book Archive